CIMETIDINE AND GASTRIC-CANCER - PRELIMINARY-REPORT FROM POST-MARKETING SURVEILLANCE STUDY

被引：45

作者：

COLINJONES, DG

LANGMAN, MJS

LAWSON, DH

VESSEY, MP

机构：

[1] GLASGOW ROYAL INFIRM,DEPT CLIN PHARMACOL,GLASGOW G4 0SF,SCOTLAND

[2] UNIV OXFORD,RADCLIFFE INFIRM,DEPT COMMUNITY MED & GEN PRACTICE,OXFORD OX2 6HE,ENGLAND

[3] UNIV NOTTINGHAM,CITY HOSP,DEPT THERAPEUT,NOTTINGHAM NG5 1PB,ENGLAND

来源：

关键词：

D O I：

10.1136/bmj.285.6351.1311

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1311 / 1313

页数：3

共 10 条

[1] BARNARD J, 1981, GUT, V22, pA873
[2] Busuttil A, 1981, J R Coll Surg Edinb, V26, P322
[3] COLINJONES D, 1981, CIMETIDINE 80S, P270
[4] ELDER JB, 1979, LANCET, V1, P1005, DOI 10.1016/S0140-6736(79)92757-0
[5] GASTRIC CARCINOMA AND PREVIOUS PEPTIC-ULCERATION
ELLIS, DJ
KINGSTON, RD
BROOKES, VS
WATERHOUSE, JAH
[J]. BRITISH JOURNAL OF SURGERY, 1979, 66 (02) : 117 - 119
[6] GREEN PHR, 1981, GASTROENTEROLOGY, V81, P247
[7] MUSCROFT TJ, 1981, LANCET, V1, P408
[8] OKABE H, 1971, GANN MONOGR CANCER R, V11, P67
[9] REED PI, 1981, LANCET, V2, P553
[10] Sakita T., 1973, CLIN GASTROENTEROL, V2, P345, DOI 10.1016/S0300-5089(21)00034-1